SEMA4 HOLDINGS SHAREHOLDER WARNING: CLAIMSFILER REMINDS INVESTORS

NEW ORLEANS, Sept. 27, 2022 (GLOBE NEWSWIRE) — ClaimsFiler, a FREE shareholder information service, is reminding investors they have until November 7, 2022 Lead Plaintiff’s Motions in a Securities Class Action Against Sema4 Holdings Corp. SMFR SMFRW))) if they purchased the securities of the Company between March 14, 2022 and August 15, 2022 inclusive (the […]

(BPMC) – ROSEN, NATIONAL TRIAL LAWYERS, Encourages Blueprint Meds

NEW YORK, Sept. 6, 2022 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Blueprint Medicines Corporation BPMC based on allegations that Blueprint Medicines may have disclosed materially misleading business information to the investing public. SO WHAT: If you have […]